Tech Company Financing Transactions
Theron Pharmaceuticals Funding Round
Theron Pharmaceuticals, operating out of Sunnyvale, received $662.6 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
5/19/2011
Transaction Type
Venture Equity
Amount
$662,550
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 San Aleso Ave.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Overview
Founded in 2008, Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/19/2011: Jibe venture capital transaction
Next: 5/19/2011: Datran Media venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record every notable VC transaction. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs